Article Information
History
- April 6, 2020.
Article Versions
- You are currently viewing Version 1 of this article (April 6, 2020 - 02:00).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Lisanna Sinisalu1,
- Partho Sen2,
- Samira Salihović1,3,
- Suvi Virtanen4,
- Heikki Hyöty5,6,
- Jorma Ilonen7,8,
- Jorma Toppari9,10,
- Riitta Veijola11,12,13,
- Matej Orešič2,3,*,#,
- Mikael Knip14,15,*,# and
- Tuulia Hyötyläinen1,*,#
- 1School of Science and Technology, Örebro University, Örebro, Sweden
- 2Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland
- 3School of Medical Sciences, Örebro University, Örebro, Sweden
- 4National Institute for Health and Welfare, Nutrition Unit, Helsinki, Helsinki, Finland
- 5Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland
- 6Fimlab Laboratories, Pirkanmaa Hospital District, Tampere, Finland
- 7Immunogenetics Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland
- 8Clinical Microbiology, Turku University Hospital, Turku, Finland
- 9Institute of Biomedicine, Centre for Integrative Physiology and Pharmacology, and Centre for Population Health Research, University of Turku, Turku, Finland
- 10Department of Pediatrics, Turku University Hospital, Turku, Finland
- 11Department of Paediatrics, PEDEGO Research Unit, Medical Research Centre, University of Oulu, Oulu, Finland
- 12Department of Children and Adolescents, Oulu University Hospital, Oulu, Finland
- 13Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden
- 14Pediatric Research Center, Children’s Hospital, University of Helsinki and Helsinki University Hospital, 00290 Helsinki, Finland; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland
- 15Center for Child Health Research, Tampere University Hospital, Tampere, Finland
- ↵#Correspondence: Matej Orešič; Email: matej.oresic{at}utu.fi, Mikael Knip; Email: mikael.knip{at}helsinki.fi, Tuulia Hyötyläinen; MTM Research Centre, School of Science and Technology, Örebro University, 702 81 Örebro, Sweden. Email: tuulia.hyotylainen{at}oru.se; Phone: +46 19 303487
Posted April 06, 2020.
Early-life exposure to perfluorinated alkyl substances modulates lipid metabolism in progression to celiac disease
